I agree with you about the effect of the capital raising on the current SP. But I love the fact that the BioInquire deal is being fully funded by equity. OK, it dilutes us if we don't participate, but also keeps the company with minimal debt (and the directors are converting their loans to equity) and means that the (very high) profit from BioInquire goes straight to us!
Also, there is a huge accummulated loss in this company, so we won't be paying tax for quite a while.
I intend to hold this stock for a number of years not minutes like the day traders. The day traders have no hope with this one because it is so illiquid.
$45m revenue per annum - market cap $7m, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $1.96K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 4699999 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7039269 | 5 |
View Market Depth
| Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
